MARKET

SGMO

SGMO

SANGAMO THERAPEU
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.41
-0.05
-0.48%
After Hours: 9.41 0 0.00% 16:00 11/15 EST
OPEN
9.53
PREV CLOSE
9.46
HIGH
9.53
LOW
9.36
VOLUME
817.98K
TURNOVER
--
52 WEEK HIGH
13.91
52 WEEK LOW
6.26
MARKET CAP
1.09B
P/E (TTM)
-8.5905
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SGMO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

SGMO News

  • Edited Transcript of SGMO earnings conference call or presentation 6-Nov-19 10:00pm GMT
  • Thomson Reuters StreetEvents.3d ago
  • Sangamo Therapeutics, Inc. 2019 Q3 - Results - Earnings Call Presentation
  • Seeking Alpha - Article.4d ago
  • Sangamo Therapeutics Announces New Scientific Advisory Board
  • Benzinga.11/08 13:36
  • Sangamo Therapeutics Announces New Scientific Advisory Board
  • Business Wire.11/08 13:30

More

Industry

Biotechnology & Medical Research
+1.25%
Pharmaceuticals & Medical Research
+1.34%

Hot Stocks

Name
Price
%Change

About SGMO

Sangamo Therapeutics, Inc., formerly Sangamo BioSciences, Inc., is a clinical-stage biotechnology company. The Company is focused on translating science into genomic therapies that transform patients' lives using the Company's platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The Company has clinical and preclinical programs in development and partnered certain programs with biopharmaceutical companies to expedite clinical and commercial development. The focus for its Company is the development of human therapeutics. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. The Company has initiated a Phase I/II clinical trial evaluating its zinc finger nuclease (ZFN) in vivo genome editing approach for the treatment of hemophilia B. In the development of its ZFP technology platform, it is focusing its resources on product development for therapeutic use in humans and on its non-therapeutic applications.
More

Webull offers Sangamo Therapeutics Inc (SGMO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.